Fundacio Privada Dau
Fundacio Privada Dau is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
Multicenter, randomised, open-label with blind evaluation active and placebo-controlled, non-inferiority clinical trial to investigate the efficacy and tolerability of Lipovir® Gel (Acyclovir 5%) compared to Zovirax® Cream (Acyclovir 5%) on patients with recurrent herpes labialis
Sponsor Laboratorios Ojer Pharma S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
An exploratory, multicenter, randomized, open-label with blind evaluation, active-controlled study to evaluate the safety and efficacy of Keramod® (imiquimod 50 mg/g, Gel) compared with Aldara® (imiquimod 50 mg/g, Cream) for the treatment of actinic keratosis in adults.
Sponsor Laboratorios Ojer Pharma S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Multicenter, randomized, open-label with blind evaluation, non-inferiority clinical trial, with parallel groups to evaluate the efficacy and safety of the topical application of Impetine® Gel (mupirocin 20 mg/g, Gel) compared with Bactroban® (mupirocin 20 mg/g, Ointment) for the treatment of impetigo in paediatric population
Sponsor Laboratorios Ojer Pharma S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Single-arm, open-label dose titration phase 2 clinical trial of (+)-α-DHTBZ for the treatment of tardive dyskinesia (TD)
Sponsor Adeptio Pharmaceuticals Limited
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Fundacio Privada Dau?
The 2026-10-09 snapshot links Fundacio Privada Dau to 4 distinct CTIS trials. Recorded services include Medicinal product management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Fundacio Privada Dau?
The most frequently recorded therapeutic areas are Dermatology, Infectious Disease. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Fundacio Privada Dau conducted?
The linked trials record locations in 3 countries, including Spain, Croatia, Poland. These are trial locations, not confirmed office locations or countries where Fundacio Privada Dau delivered services.
What can this page tell me about Fundacio Privada Dau's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Fundacio Privada Dau. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Fundacio Privada Dau